ciprofloxacin has been researched along with amphotericin b in 128 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.56) | 18.7374 |
1990's | 11 (8.59) | 18.2507 |
2000's | 44 (34.38) | 29.6817 |
2010's | 65 (50.78) | 24.3611 |
2020's | 6 (4.69) | 2.80 |
Authors | Studies |
---|---|
Clark, AM; ElSohly, HN; Jacob, MR; Pasco, DS; Walker, LA; Zhang, Z | 1 |
Malan, SF; Swart, H; Van Dyk, S | 1 |
Maiese, WM; Singh, MP; Timmermann, BN; Wächter, G; Woldemichael, GM | 1 |
Dunbar, DC; Ferreira, D; Jacob, MR; Li, XC; Muhammad, I; Tekwani, BL | 1 |
Charman, WN; Hamann, MT; Hammond, NL; Mayer, AM; McIntosh, KA; Peng, J; Wahyuono, S; Yousaf, M | 1 |
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S | 1 |
Jolivette, LJ; Ward, KW | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abbas, HK; Herath, WH; Jacob, MR; Jayasinghe, L; Nanayakkara, NP | 1 |
Jin, W; Zjawiony, JK | 1 |
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL | 1 |
Bharate, SB; Chauthe, SK; Jacob, MR; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL; Yunus, NA | 1 |
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Patel, SR; Patil, P; Tekwani, BL | 1 |
Ablordeppey, SY; Fan, P; Jacob, M; Khan, A; Khan, S; Li, S; Mardenborough, LG; Walker, L; Zhang, W; Zhu, XY | 1 |
Aridoss, G; Balasubramanian, S; Kabilan, S; Parthiban, P | 1 |
Adamec, J; Beckert, R; Buchta, V; Kaustová, J; Klimesová, V; Möllmann, U; Waisser, K; Weiss, D | 1 |
Dahse, HM; Fu, H; Grabley, S; Han, L; Huang, X; Lin, W; Moellmann, U; Sattler, I | 1 |
Holla, BS; Karthikeyan, MS; Kumari, NS | 1 |
Hamann, MT; Kasanah, N; Shilabin, AG; Wedge, DE | 1 |
Bharate, SB; Jacob, M; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL | 1 |
Aridoss, G; Jeong, YT; Kabilan, S; Parthiban, P; Prakash, M; Ramachandran, R | 1 |
Karthikeyan, MS | 2 |
Doerksen, RJ; Hamann, MT; Ibrahim, MA; Jacob, M; Khan, SI; Prasanna, S; Shilabin, AG | 1 |
Hamann, MT; Kasanah, N; Shilabin, AG; Tekwani, BL | 1 |
Ding, Y; Ferreira, D; Jacob, M; Li, XC; Manly, SP; Radwan, MM; Rodríguez-Guzmán, R; Ross, SA | 1 |
Ashfaq, MK; Jacob, MR; Joshi, VC; Khan, SI; Manly, SP; Muhammad, I; Samoylenko, V; Tekwani, BL; Walker, LA | 1 |
Barsoum, FF; Girgis, AS; Samir, A | 1 |
Ahmed, SA; Elsohly, MA; Khan, IA; Radwan, MM; Ross, SA; Slade, D | 1 |
Aridoss, G; Kabilan, S; Parthiban, P; Ramkumar, V; Rathika, P | 2 |
Ansari, KF; Lal, C | 1 |
Amirthaganesan, S; Aridoss, G; Jeong, YT; Kim, JT; Kim, MS | 1 |
Jain, R; Reddy, RP; Sharma, RK; Tegge, W | 1 |
Chitra, S; Devanathan, D; Pandiarajan, K | 1 |
Hamann, MT; Kudrimoti, S; Peng, J; Tekwani, BL; Wahba, AE | 1 |
Ahmed, SA; Elsohly, MA; Galal, AM; Gul, W; Jacob, MR; Khan, SI; Radwan, MM; Ross, SA; Slade, D; Tekwani, BL | 1 |
Cho, SJ; Park, KD | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choo, YM; Doerksen, RJ; Gertsch, J; Hamann, MT; Jacob, MR; Khan, SI; Kudrimoti, S; Madgula, V; Mayer, AM; Odde, S; Peng, J; Pennaka, HK; Prasanna, S; Rao, KV; Tekwani, BL; Tu, LC; Wang, B | 1 |
Abbott, S; Lauzon, C; Penney, C; Perron, V; Saleh, M; Zacharie, B | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ferreira, D; Fronczek, FR; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP | 1 |
Abdullah, ST; Ahmed, SK; Azeeza, S; Kamal, A; Khan, IA; Reddy, AM; Sharma, S; Shetti, RV; Swapna, P | 1 |
Rane, RA; Telvekar, VN | 1 |
Balaji, B; Kabilan, S; Ramanathan, M; Umamatheswari, S | 1 |
Ablordeppey, SY; Etukala, JR; Jacob, MR; Khan, SI; Mazu, TK; Walker, LA | 1 |
Hamann, MT; Shilabin, AG | 1 |
Miller, MJ; Oliver, AG; Rudloff, JR; Wencewicz, TA; Yang, B | 1 |
de Koning, CB; Johnson, MM; Omolo, JJ; van Vuuren, SF | 1 |
Abdel-Megeed, MF; Azaam, MM; Badr, BE; El-Hiti, GA | 1 |
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Singh, PP; Singh, S; Tekwani, BL | 1 |
Duke, SO; Ferreira, D; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP; Tekwani, BL | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Gutte, SD; Rane, RA; Sahu, NU | 1 |
Cutler, HG; Cutler, SJ; Dugan, FM; Gao, J; Hill, RA; Jacob, MR; Khan, SI; León, F; Lupien, S; Radwan, MM; Tekwani, BL; Wang, X | 1 |
Bharate, JB; Bharate, SB; Jacob, MR; Khan, IA; Khan, SI; Maity, S; Mudududdla, R; Sharma, PR; Singh, B; Tekwani, BL; Vishwakarma, RA; Yadav, RR | 1 |
Kalinin, AA; Kulik, NV; Mamedov, VA; Voloshina, AD; Zobov, VV | 1 |
Haridas, KR; Kumari, NS; Rajeesh, P; Ranjith, PK; Rishikesan, R; Row, TN; Susanta, NK | 1 |
Kariyappa, AK; Nagamallu, R | 1 |
Maravić, A; Odžak, R; Skočibušić, M | 1 |
Bangalore, P; Borhade, SD; Khandare, PK; Rane, RA | 1 |
Ablordeppey, SY; Boateng, C; Bolden, S; Etukala, JR; Flores-Rozas, H; Jacob, MR; Khan, SI; Mazu, T; Walker, LA; Zhu, XY | 1 |
Cao, Y; Chen, X; Han, L; Huang, X; Jiang, C; Jiang, Y; Liu, J; Zhang, J; Zheng, D | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Haridas, KR; Kumari, SN; Pakkath, R; Ranjith, PK | 1 |
Aneja, KR; Khurana, JM; Sharma, C; Sindhu, J; Singh, H | 1 |
Bagra, N; Jacob, MR; Jain, R; Khan, SI; Mahindra, A; Wangoo, N | 2 |
Bangalore, PK; Karpoormath, R; Naphade, SS; Palkar, MB; Rane, RA; Shaikh, MS | 1 |
Jacob, MR; Jain, R; Khan, SI; Mahindra, A; Rathore, D; Sharma, KK | 1 |
Hoffmeister, D; Nett, M; Pauly, J | 1 |
Abdel-baky, AM; Bishay, DW; Cutler, SJ; Ibrahim, MA; Malak, LG; Moharram, AM; Ross, SA; Tekwani, B | 1 |
Bisht, GS; Cameotra, SS; Kalanta, A; Lohan, S; Sonkusre, P | 1 |
Kaushik, D; Kaushik, P; Khloya, P; Kumar, S; Sharma, PK; Surain, P | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Al-Balas, Q; Al-Gharaibeh, M; Alali, F; Albataineh, H; Chen, WL; El-Elimat, T; Falkinham, JO; Oberlies, NH; Swanson, SM | 1 |
Chen, X; Ding, N; Han, L; Huang, X; Jiang, C; Jiang, Y; Li, L; Liu, J; Ma, J; Mu, Y; Qu, X | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Coleman, C; Ferreira, D; Fronczek, FR; Hetta, MH; Ibrahim, MA; Jacob, MR; Khan, SI; Mohammed, R; Muhammad, I; Nanayakkara, NP; Samoylenko, V; Zaki, MA | 1 |
Crespín, GD; Daranas, AH; Febles, M; Fernández, JJ; Montalvão, S; Norte, M; Padrón, JM; Tammela, P | 1 |
Jacob, MR; Jain, R; Khan, SI; Kumar, V; Maurya, IK; Sharma, KK; Shenmar, K; Tikoo, K; Wangoo, N | 1 |
Jacob, MR; Jain, R; Khan, SI; Kumar, V; Maurya, IK; Sharma, KK; Tikoo, K | 1 |
Abdel-Aziz, MM; Abdelrahman, MA; Elaasser, MM; Gomaa, MS; Salama, I; Soliman, DH | 1 |
Carvalho, P; Cutler, SJ; Dale, OR; Elokely, KM; ElSohly, MA; Galal Osman, A; Gul, W; Husni, AS; Khan, S; Klein, ML; Radwan, M; Ross, SA; Slade, D; Yadav, VK | 1 |
Chen, Y; Paetz, C; Schneider, B | 1 |
Chou, S; Dou, X; Shan, A; Song, J; Wang, J; Wang, Z; Yang, Y; Yang, Z | 1 |
Chen, S; He, S; Liu, X; Qiu, G; Shi, J; Tang, W; Wu, X; Xu, K; Zhang, J | 1 |
Abdel Gawad, NM; Abdel-Aziz, MM; Abo-Ashour, MF; Abou-Seri, SM; Bhakta, S; Elaasser, MM; Eldehna, WM; George, RF; Gupta, A | 1 |
Zhang, B | 1 |
Mudalungu, CM; Rückert, C; Schmitz, S; Sekurova, ON; Süssmuth, RD; Voigt, K; von Törne, WJ; Zotchev, SB | 1 |
Bhagat, K; Gulati, HK; Kinarivala, N; Kumar, N; Sanduja, M; Sharma, S; Singh, H; Singh, JV | 1 |
Ali, Z; Bae, JY; Chittiboyina, AG; Khan, IA; Viljoen, AM; Wang, YH; Zaki, AA | 1 |
Askar, AA; El-Khalafawy, A; Makhlouf, AH; Ragab, A; Salem, MA | 1 |
Capito, JE; El-Manawaty, MA; George, RF; Girgis, AS; Panda, SS; Salman, A; Samir, A; Thomas, SJ | 1 |
Fujita, K; Ikuta, M; Kakeya, H; Nishimura, S; Sugiyama, R; Yoshimura, A | 1 |
Balluff, S; Beemelmanns, C; Schalk, F; Seibel, E; Um, S | 1 |
Agarwal, AK; Bateman, A; Choo, YM; Goldberg, A; Hamann, MT; Miller, SG; Mitchell, AJ; Peng, J; Schumacher, RA; Schumacher, RW; Thiele, J; Tripathi, SK; Waters, AL; Zou, Y | 1 |
Baglin, TP; Marcus, RE; Warren, RE; Wimperis, JZ | 1 |
Dekker, AW; Rozenberg-Arska, M; Verdonck, LF | 2 |
Haverkorn, MJ | 1 |
Petrou, MA; Rogers, TR | 1 |
Boyce, ST; Holder, IA; Warden, GD | 1 |
Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM | 1 |
Andersson, J; Bergström, SE; Heurlin, N; Ljungman, P; Lönnqvist, B; Ringden, O; Winiarski, J | 1 |
Benzer, H; Berger, J; Javorsky, F; Lejeune, P; Lingnau, W; Mutz, N | 1 |
Chen, RJ; Liu, XP; Sugar, AM | 1 |
Canver, CC; Kosolcharoen, P; Patel, AK; Voytovich, MC | 1 |
Betts, RF; Blair, EA; Flesher, WR; Griggs, JJ; Norton, JR; Rowe, JM | 1 |
de Vries, EG; Hospers, GA; Mulder, NH; Schröder, CP; Sleijfer, DT; van der Graaf, WT; Willemse, PH | 1 |
Dietz, A; Markkanen, H; Nikanne, E; Nuutinen, J; Ruoppi, P; Seppa, J | 1 |
Cooke, RH; Fedorko, DP; Lucey, DR; Stock, F; Tarr, PE | 1 |
Domínguez, I; García Serrano, JL; Serrano Laborda, D | 1 |
Berggren, RE; Chaney, S; Gopalan, R | 1 |
Bakker-Woudenberg, IA; Becker, MJ; Guo, L; Schiffelers, RM; Storm, G | 1 |
Ersoy, F; Gumruk, F; Kara, A; Sanal, O; Secmeer, G; Tezcan, I; Turkkani, G; Yel, L | 1 |
Kannan, A; Pant, A; Upreti, RK | 1 |
Suliman, S; van Vuuren, SF; Viljoen, AM | 1 |
Jongwutiwes, U; Malathum, K; Sungkanuparph, S | 1 |
Kumar, K; Sharma, C; Singh, DP | 1 |
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
Meletiadis, J; Papaioannidou, P; Roilides, E; Sein, T; Stergiopoulou, T; Walsh, TJ | 1 |
Blennow, O; Ljungman, P; Mattsson, J; Remberger, M; Sparrelid, E | 1 |
Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M | 1 |
Jandaik, S; Kumar, S; Sharma, N | 1 |
Jandhyala, D; Sohail, MR; Stahr, DC; Tan, EM | 1 |
Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
3 review(s) available for ciprofloxacin and amphotericin b
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids.
Topics: Chemistry, Pharmaceutical; Coumarins; Humans; Structure-Activity Relationship | 2019 |
4 trial(s) available for ciprofloxacin and amphotericin b
Article | Year |
---|---|
Infection prevention in autologous bone marrow transplantation and the role of protective isolation.
Topics: Adolescent; Adult; Amphotericin B; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Patient Isolation; Prospective Studies; Transplantation, Autologous | 1994 |
Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Translocation; Ciprofloxacin; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intestines; Male; Multiple Trauma; Pneumonia; Prospective Studies; Respiration, Artificial; Tobramycin | 1997 |
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
Topics: Adult; Amphotericin B; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Piperacillin; Prospective Studies; Time Factors; Vancomycin | 1998 |
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ciprofloxacin; Costs and Cost Analysis; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Fever; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Length of Stay; Leukopenia; Methotrexate; Middle Aged; Neoplasm Metastasis; Netherlands; Prospective Studies; Recombinant Proteins | 1999 |
121 other study(ies) available for ciprofloxacin and amphotericin b
Article | Year |
---|---|
New sesquiterpenoids from the root of Guatteria multivenia.
Topics: Alkaloids; Annonaceae; Anti-Bacterial Agents; Anti-Infective Agents; Aporphines; Aspartic Acid Endopeptidases; Candida albicans; Cryptococcus neoformans; Inhibitory Concentration 50; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peru; Plant Roots; Plants, Medicinal; Protease Inhibitors; Sesquiterpenes; Staphylococcus aureus | 2002 |
The activity of p-methoxybenzylisothiocyanate against Neisseria gonorrhoeae, Haemophilus ducreyi, and other microorganisms.
Topics: Bacteria; Cell Division; Haemophilus ducreyi; Isothiocyanates; Lepidium; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Plant Preparations | 2002 |
Antibacterial diterpenes from Calceolaria pinifolia.
Topics: Animals; Anti-Bacterial Agents; Argentina; Bacillus subtilis; Diterpenes; Erythrocytes; Escherichia coli; Female; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Plants, Medicinal; Scrophulariaceae; Staphylococcus aureus | 2003 |
Antimicrobial and antiparasitic (+)-trans-hexahydrodibenzopyrans and analogues from Machaerium multiflorum.
Topics: Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Benzopyrans; Candida albicans; Fabaceae; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peru; Plant Bark; Plants, Medicinal; Plasmodium falciparum; Staphylococcus aureus; Stereoisomerism | 2003 |
New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antifungal Agents; Biological Availability; Carbazoles; Carbolines; Fourier Analysis; HIV-1; Indoles; Injections, Intravenous; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Porifera; Pyrroles; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2004 |
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.
Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
N-Methyl-4-hydroxy-2-pyridinone analogues from Fusarium oxysporum.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Fusarium; Molecular Structure; Mycobacterium; Pyridones | 2006 |
5-alkylresorcinols from Merulius incarnatus.
Topics: Agaricales; Animals; Anti-Infective Agents; Candida albicans; Chlorocebus aethiops; Inhibitory Concentration 50; Leishmania; Methicillin Resistance; Microbial Sensitivity Tests; Resorcinols; Staphylococcus aureus; Stereoisomerism; Vero Cells | 2006 |
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship | 2006 |
Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Cryptococcus neoformans; Epithelial Cells; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Phloroglucinol; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines.
Topics: Aminoquinolines; Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiparasitic Agents; Bacteria; Chlorocebus aethiops; Erythrocytes; Fungi; Humans; Indicators and Reagents; L-Lactate Dehydrogenase; Leishmania donovani; Magnetic Resonance Spectroscopy; Methemoglobin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Bacteria; Cell Line; Cell Survival; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; Fungi; Humans; Indicators and Reagents; Indole Alkaloids; Indoles; Isomerism; Leishmania donovani; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis, stereochemistry and antimicrobial evaluation of some N-morpholinoacetyl-2,6-diarylpiperidin-4-ones.
Topics: Anti-Infective Agents; Bacteria; Fungi; Molecular Structure; Morpholines; Structure-Activity Relationship | 2007 |
Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antitubercular Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, Thin Layer; Estrone; Fungi; Heterocyclic Compounds; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2007 |
Unusual naphthoquinone derivatives from the twigs of Avicennia marina.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Avicennia; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Mice; Molecular Structure; Naphthoquinones; Plant Stems; Plants, Medicinal; Structure-Activity Relationship | 2007 |
Synthesis and antimicrobial studies of novel dichlorofluorophenyl containing aminotriazolothiadiazines.
Topics: Anti-Bacterial Agents; Antifungal Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared; Thiazines; Thiazoles | 2008 |
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
Topics: Antifungal Agents; Antineoplastic Agents; Antiparasitic Agents; Cell Line, Tumor; Depsipeptides; Drug Screening Assays, Antitumor; Fusarium; Humans; Lysosomes; Microbiological Techniques; Mycobacterium tuberculosis; Opportunistic Infections; Parasitic Sensitivity Tests; Receptor, ErbB-3; Structure-Activity Relationship | 2007 |
S-Euglobals: biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Biomimetic Materials; Leishmania donovani; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium avium Complex; Phloroglucinol; Plasmodium falciparum; Staphylococcus aureus; Structure-Activity Relationship; Terpenes | 2008 |
Synthesis and spectral characterization of a new class of N-(N-methylpiperazinoacetyl)-2,6-diarylpiperidin-4-ones: antimicrobial, analgesic and antipyretic studies.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Anti-Infective Agents; Bacteria; Drug Evaluation, Preclinical; Fungi; Mice; Microbial Sensitivity Tests; Molecular Structure; Pain; Piperidines; Spectrum Analysis; Structure-Activity Relationship | 2009 |
Synthesis, analgesic, anti-inflammatory and antimicrobial studies of 2,4-dichloro-5-fluorophenyl containing thiazolotriazoles.
Topics: Analgesics; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Microbial Sensitivity Tests; Spectrum Analysis; Structure-Activity Relationship; Thiazoles; Triazoles | 2009 |
2-N-Methyl modifications and SAR studies of manzamine A.
Topics: Animals; Antimalarials; Carbazoles; Carbolines; Chlorocebus aethiops; Erythrocytes; Fibroblasts; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Kidney; Methylation; Models, Molecular; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells | 2008 |
Kinetic studies and bioactivity of potential manzamine prodrugs.
Topics: Administration, Oral; Animals; Antimalarials; Candida albicans; Carbolines; Chlorocebus aethiops; Cryptococcus neoformans; Disease Models, Animal; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Prodrugs; Vero Cells | 2008 |
Sorocenols G and H, anti-MRSA oxygen heterocyclic Diels-Alder-type adducts from Sorocea muriculata roots.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Benzofurans; Candida albicans; Cryptococcus neoformans; Inhibitory Concentration 50; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Moraceae; Oxygen; Peru; Plant Extracts; Plant Roots; Staphylococcus aureus; Stilbenes | 2008 |
Indolizidine, antiinfective and antiparasitic compounds from Prosopis glandulosa var. glandulosa.
Topics: Animals; Anti-Infective Agents; Antiparasitic Agents; Aspergillus fumigatus; Brain; Candida albicans; Chloroquine; Cryptococcus neoformans; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Indolizidines; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Nevada; Plants, Medicinal; Plasmodium berghei; Prosopis | 2009 |
Regioselective synthetic approaches towards 1,2,8,9-tetraazadispiro[4.1.4.2]trideca-2,9-dien-6-ones of potential antimicrobial properties.
Topics: Anti-Infective Agents; Candida albicans; Crystallography, X-Ray; Drug Design; Enterococcus faecalis; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Proteus vulgaris; Pyrazoles; Spiro Compounds; Staphylococcus aureus; Stereoisomerism; Streptococcus agalactiae; Structure-Activity Relationship | 2009 |
Biologically active cannabinoids from high-potency Cannabis sativa.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Aspergillus fumigatus; Candida; Cannabinoids; Cannabis; Chlorocebus aethiops; Escherichia coli; Gas Chromatography-Mass Spectrometry; Leishmania donovani; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Plasmodium falciparum; Pseudomonas aeruginosa | 2009 |
Synthesis, spectral, crystal and antimicrobial studies of biologically potent oxime ethers of nitrogen, oxygen and sulfur heterocycles.
Topics: Anti-Bacterial Agents; Antifungal Agents; Crystallography, X-Ray; Ethers; Heterocyclic Compounds; Microbial Sensitivity Tests; Nitrogen; Oximes; Oxygen; Stereoisomerism; Sulfur | 2009 |
Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzimidazoles; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2009 |
Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Fungi; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles; Thiazolidines | 2009 |
Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides.
Topics: Antimicrobial Cationic Peptides; Bacteria; Dipeptides; Drug Discovery; Fungi; Microbial Sensitivity Tests | 2009 |
Synthesis and in vitro microbiological evaluation of novel 4-aryl-5-isopropoxycarbonyl-6-methyl-3,4-dihydropyrimidinones.
Topics: Anti-Infective Agents; Bacteria; Catalysis; Chlorides; Fungi; Pyrimidinones; Scandium | 2010 |
Structure-activity relationship studies of manzamine A: amidation of positions 6 and 8 of the beta-carboline moiety.
Topics: Administration, Oral; Amides; Animals; Antimalarials; Carbazoles; Carbolines; Male; Mice; Mycobacterium avium Complex; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2009 |
Synthesis, stereochemistry and antimicrobial studies of novel oxime ethers of aza/diazabicycles.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bridged Bicyclo Compounds; Ethers; Fungi; Oximes | 2009 |
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
Topics: Acetals; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Cryptococcus neoformans; Dimerization; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization | 2009 |
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
Topics: Anti-Infective Agents; Bacteria; Camellia sinensis; Catechin; Drug Design; Drug Stability; Fungi; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Structure; Tea | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.
Topics: Animals; Anti-Infective Agents; Carbazoles; Cerebellar Diseases; Indole Alkaloids; Mice; Microbial Sensitivity Tests; Molecular Structure; Neurogenic Inflammation; Porifera; Stereoisomerism; Structure-Activity Relationship | 2010 |
Synthesis and antimicrobial activity of 2-fluorophenyl-4,6-disubstituted [1,3,5]triazines.
Topics: Anti-Infective Agents; Candida albicans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Triazines | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Bioactive 1,4-dihydroxy-5-phenyl-2-pyridinone alkaloids from Septoria pistaciarum.
Topics: Alkaloids; Animals; Antimalarials; Ascomycota; Chlorocebus aethiops; Chloroquine; Crystallography, X-Ray; Methicillin-Resistant Staphylococcus aureus; Molecular Conformation; Molecular Structure; Plasmodium falciparum; Pyridones | 2010 |
Anti-tubercular agents. Part 5: synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners.
Topics: Animals; Antitubercular Agents; Bacteria; Benzothiadiazines; Cell Line; Cell Survival; Female; Fungi; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Synthesis and evaluation of novel chloropyrrole molecules designed by molecular hybridization of common pharmacophores as potential antimicrobial agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Design; Hydrazines; Microbial Sensitivity Tests; Phenols; Pyrroles; Structure-Activity Relationship | 2010 |
Synthesis and antimicrobial studies of thiazolotriazinones.
Topics: Anti-Infective Agents; Cyclization; Magnetic Resonance Spectroscopy; Spectrophotometry, Infrared; Thiazines; Triazines | 2010 |
Synthesis, stereochemistry, antimicrobial evaluation and QSAR studies of 2,6-diaryltetrahydropyran-4-one thiosemicarbazones.
Topics: Anti-Infective Agents; Bacteria; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Stereoisomerism; Thiosemicarbazones | 2011 |
δ-Carbolines and their ring-opened analogs: synthesis and evaluation against fungal and bacterial opportunistic pathogens.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Carbolines; Chlorocebus aethiops; Dose-Response Relationship, Drug; Fibroblasts; Fungi; Microbial Sensitivity Tests; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Vero Cells | 2011 |
In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Depsipeptides; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Microbial Sensitivity Tests; Structure-Activity Relationship | 2011 |
N-O chemistry for antibiotics: discovery of N-alkyl-N-(pyridin-2-yl)hydroxylamine scaffolds as selective antibacterial agents using nitroso Diels-Alder and ene chemistry.
Topics: Alkenes; Anti-Bacterial Agents; Colony Count, Microbial; Crystallography, X-Ray; Drug Resistance, Bacterial; Gram-Positive Bacteria; Hydroxylamines; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Pyridines; Stereoisomerism; Structure-Activity Relationship | 2011 |
The synthesis of xanthones, xanthenediones, and spirobenzofurans: their antibacterial and antifungal activity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzofurans; Benzoquinones; Candida albicans; Cryptococcus neoformans; Molecular Structure; Spiro Compounds; Xanthones | 2011 |
Synthesis, antimicrobial and anticancer activities of a novel series of diphenyl 1-(pyridin-3-yl)ethylphosphonates.
Topics: Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Organophosphonates; Phosphorous Acids; Pyridines | 2012 |
Amino acid, dipeptide and pseudodipeptide conjugates of ring-substituted 8-aminoquinolines: synthesis and evaluation of anti-infective, β-haematin inhibition and cytotoxic activities.
Topics: Amino Acids; Aminoquinolines; Animals; Anti-Infective Agents; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Dipeptides; Fungi; Hemeproteins; Leishmania donovani; Mice; Peptidomimetics; Plasmodium falciparum; Vero Cells | 2012 |
Antiprotozoal and antimicrobial compounds from the plant pathogen Septoria pistaciarum.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Ascomycota; Aspergillus fumigatus; Candida albicans; Candida glabrata; Chlorocebus aethiops; Chloroquine; Cryptococcus neoformans; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium avium Complex; Plasmodium falciparum; Pseudomonas aeruginosa; Staphylococcus aureus; Vero Cells | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and evaluation of novel 1,3,4-oxadiazole derivatives of marine bromopyrrole alkaloids as antimicrobial agent.
Topics: Alkaloids; Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Halogenation; Humans; Microbial Sensitivity Tests; Mycoses; Oxadiazoles; Pyrroles | 2012 |
Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens.
Topics: | 2012 |
Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
Topics: Antiprotozoal Agents; Drug Discovery; Humans; Indoles; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis, Visceral; Models, Chemical; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2013 |
Antimicrobial activity of imidazo[1,5-a]quinoxaline derivatives with pyridinium moiety.
Topics: Animals; Anti-Infective Agents; Bacteria; Drug Design; Female; Fungi; Imidazoles; Male; Mice; Microbial Sensitivity Tests; Pyridinium Compounds | 2013 |
Design and synthesis of positional isomers of 5 and 6-bromo-1-[(phenyl)sulfonyl]-2-[(4-nitrophenoxy)methyl]-1H-benzimidazoles as possible antimicrobial and antitubercular agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Benzimidazoles; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Klebsiella pneumoniae; Models, Molecular; Molecular Structure; Mycobacterium; Rhizopus; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of novel formyl-pyrazoles bearing coumarin moiety as potent antimicrobial and antioxidant agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Coumarins; Molecular Structure; Pyrazoles; Structure-Activity Relationship | 2013 |
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Multiple; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imidazoles; Microbial Sensitivity Tests; Mycoses; Oximes | 2013 |
Synthesis and evaluation of novel 4-nitropyrrole-based 1,3,4-oxadiazole derivatives as antimicrobial and anti-tubercular agents.
Topics: Animals; Antibiotics, Antitubercular; Antifungal Agents; Bacillus subtilis; Candida albicans; Chlorocebus aethiops; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Pyrroles; Staphylococcus aureus; Structure-Activity Relationship; Vero Cells | 2013 |
Structure-activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Quinolinium Compounds; Structure-Activity Relationship; Vero Cells | 2013 |
Violapyrones A-G, α-pyrone derivatives from Streptomyces violascens isolated from Hylobates hoolock feces.
Topics: Animals; Anti-Bacterial Agents; Aspergillus niger; Bacillus subtilis; Candida albicans; Feces; Gram-Negative Bacteria; Gram-Positive Bacteria; Hylobates; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Pyrones; Staphylococcal Infections; Staphylococcus aureus; Streptomyces | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis and characterization of new N-(4-(4-chloro-1H-imidazol-1-yl)-3-methoxyphenyl)amide/sulfonamide derivatives as possible antimicrobial and antitubercular agents.
Topics: Amides; Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Structure-Activity Relationship; Sulfonamides | 2014 |
Ultrasound promoted one pot synthesis of novel fluorescent triazolyl spirocyclic oxindoles using DBU based task specific ionic liquids and their antimicrobial activity.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bridged Bicyclo Compounds, Heterocyclic; Combinatorial Chemistry Techniques; Dose-Response Relationship, Drug; Escherichia coli; Fluorescent Dyes; Indoles; Ionic Liquids; Microbial Sensitivity Tests; Molecular Structure; Oxindoles; Pseudomonas aeruginosa; Spiro Compounds; Staphylococcus aureus; Structure-Activity Relationship; Triazoles; Ultrasonics | 2014 |
Synthetically modified L-histidine-rich peptidomimetics exhibit potent activity against Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus neoformans; Dose-Response Relationship, Drug; Histidine; Microbial Sensitivity Tests; Molecular Conformation; Peptidomimetics; Structure-Activity Relationship | 2014 |
Synthesis of novel 4-nitropyrrole-based semicarbazide and thiosemicarbazide hybrids with antimicrobial and anti-tubercular activity.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Dose-Response Relationship, Drug; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrroles; Semicarbazides; Staphylococcus aureus; Structure-Activity Relationship | 2014 |
Discovery of Short Peptides Exhibiting High Potency against Cryptococcus neoformans.
Topics: | 2014 |
Synthesis and Antimicrobial Activities of His(2-aryl)-Arg and Trp-His(2-aryl) Classes of Dipeptidomimetics.
Topics: | 2014 |
Ralfuranone Is Produced by an Alternative Aryl-Substituted γ-Lactone Biosynthetic Route in Ralstonia solanacearum.
Topics: 4-Butyrolactone; Cyclization; Furans; Lactones; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ralstonia solanacearum | 2014 |
Antileishmanial metabolites from Geosmithia langdonii.
Topics: Antineoplastic Agents, Phytogenic; Aspergillus fumigatus; Benzhydryl Compounds; Candida; Cyclohexanones; Escherichia coli; Hypocreales; Leishmania donovani; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium avium Complex; Plasmodium falciparum; Pseudomonas aeruginosa; Salicylates | 2014 |
Development of novel membrane active lipidated peptidomimetics active against drug resistant clinical isolates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Cationic Peptides; Bacteria; Drug Resistance, Bacterial; Drug Resistance, Fungal; Erythrocytes; Fungi; Humans; Microbial Sensitivity Tests; Molecular Structure; Peptidomimetics | 2014 |
Synthesis and biological evaluation of pyrazolylthiazole carboxylic acids as potent anti-inflammatory-antimicrobial agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Carboxylic Acids; Edema; Fungi; Gram-Positive Bacteria; Indomethacin; Microbial Sensitivity Tests; Pyrazoles; Rats; Thiazoles | 2015 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Cytotoxic Homoisoflavones from the Bulbs of Bellevalia eigii.
Topics: HT29 Cells; Humans; Inhibitory Concentration 50; Isoflavones; Jordan; Liliaceae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Mycobacterium smegmatis; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Structure-Activity Relationship; Vinblastine | 2015 |
Bafilomycins and Odoriferous Sesquiterpenoids from Streptomyces albolongus Isolated from Elephas maximus Feces.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida; Elephants; Feces; Fermentation; Humans; Inhibitory Concentration 50; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Sesquiterpenes; Stereoisomerism; Streptomyces | 2016 |
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
Topics: Antineoplastic Agents, Phytogenic; Candida albicans; Chalcones; Cryptococcus neoformans; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Escherichia coli; Eugenia; Flavanones; Flavonoids; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium avium Complex; Nuclear Magnetic Resonance, Biomolecular; Plant Leaves; Pseudomonas aeruginosa; Puerto Rico; Staphylococcus aureus | 2016 |
Synthesis and biological evaluation of crown ether acyl derivatives.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Candida albicans; Candidiasis; Cell Line, Tumor; Cell Proliferation; Crown Ethers; Drug Screening Assays, Antitumor; Humans; Neoplasms; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Synthesis, stability and mechanistic studies of potent anticryptococcal hexapeptides.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cell Membrane; Cryptococcus neoformans; Drug Stability; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Peptides; Staphylococcus aureus | 2017 |
Discovery of a Membrane-Active, Ring-Modified Histidine Containing Ultrashort Amphiphilic Peptide That Exhibits Potent Inhibition of Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Membrane; Chlorocebus aethiops; Cryptococcus neoformans; DNA Damage; Drug Stability; Fluconazole; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Oligopeptides; Structure-Activity Relationship; Surface-Active Agents; Swine; Vero Cells | 2017 |
Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cell Line; Dose-Response Relationship, Drug; Drug Design; Fibroblasts; Fungi; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Quantitative Structure-Activity Relationship; Quinolones | 2017 |
Bioactive products from singlet oxygen photooxygenation of cannabinoids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fungi; Humans; Leishmania major; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Photochemical Processes; Plasmodium falciparum; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Singlet Oxygen | 2018 |
Precursor-Directed Biosynthesis of Phenylbenzoisoquinolindione Alkaloids and the Discovery of a Phenylphenalenone-Based Plant Defense Mechanism.
Topics: Aldehydes; Alkaloids; Amines; Amino Acids; Glucosides; Lactones; Magnoliopsida; Peptides; Phenalenes; Plant Extracts; Plants | 2018 |
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Fungal; HEK293 Cells; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Membranes; Inverted Repeat Sequences; Mice; Models, Molecular; Peptides; Protein Conformation; RAW 264.7 Cells | 2018 |
Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Bacillus cereus; Dose-Response Relationship, Drug; Free Radicals; Hydrogen Bonding; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Novel indole-thiazolidinone conjugates: Design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cell Line; Dose-Response Relationship, Drug; Drug Design; Fungi; Humans; Indoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Phenotype; RAW 264.7 Cells; Structure-Activity Relationship; Thiazolidines | 2018 |
Noursamycins, Chlorinated Cyclohexapeptides Identified from Molecular Networking of Streptomyces noursei NTR-SR4.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Halogenation; Molecular Structure; Multigene Family; Peptides, Cyclic; Streptomyces; Substrate Specificity | 2019 |
Anthraquinone-Based Specialized Metabolites from Rhizomes of
Topics: Anthraquinones; Anti-Bacterial Agents; Antifungal Agents; Asphodelaceae; Microbial Sensitivity Tests; Molecular Structure; Rhizome; Spectrum Analysis | 2019 |
One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
Topics: Anti-Bacterial Agents; Antifungal Agents; Arylsulfonates; DNA Gyrase; Dose-Response Relationship, Drug; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Immunologic Factors; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Spiro Compounds; Structure-Activity Relationship; Topoisomerase Inhibitors | 2020 |
Synthesis, pharmacological profile and 2D-QSAR studies of curcumin-amino acid conjugates as potential drug candidates.
Topics: Amino Acids; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Carrageenan; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Edema; Mice; Microbial Sensitivity Tests; Molecular Structure; Pain; Pseudomonas aeruginosa; Quantitative Structure-Activity Relationship; Rats; Salmonella typhi; Spleen; Staphylococcus aureus; Streptococcus pyogenes; Ulcer | 2020 |
Amphiol, an Antifungal Fungal Pigment from
Topics: Antifungal Agents; Ascomycota; Aspergillus fumigatus; Candida albicans; Japan; Molecular Structure; Pigments, Biological; Soil Microbiology | 2021 |
Targeted Isolation of Saalfelduracin B-D from
Topics: Amycolatopsis; Anti-Infective Agents; Antibiosis; Biological Products; Caves; Chromatography, High Pressure Liquid; Coculture Techniques; Germany; Metabolomics; Microbial Sensitivity Tests; Molecular Structure; Peptides; Tandem Mass Spectrometry | 2021 |
Structure and Antimicrobial Activity of Rare Lactone Lipids from the Sooty Mold (
Topics: Anti-Infective Agents; Antifungal Agents; Ascomycota; Cryptococcus neoformans; Lactones; Lipids; Molecular Structure | 2022 |
An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts.
Topics: Adolescent; Adult; Amphotericin B; Bacteremia; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Transplantation, Autologous; Vancomycin | 1991 |
Prevention of bacteremias caused by alpha-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatment.
Topics: Acute Disease; Adult; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Combined Modality Therapy; Drug Evaluation; Drug Therapy, Combination; Humans; Leukemia; Roxithromycin; Sepsis; Streptococcal Infections | 1990 |
Prophylaxis of respiratory tract infection in patients on artificial respiration.
Topics: Amphotericin B; Bronchitis; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Feces; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Pharynx; Pilot Projects; Respiration, Artificial; Respiratory Tract Infections; Sputum | 1989 |
In-vitro activity of antifungal agents in combination with four quinolones.
Topics: 4-Quinolones; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Candida albicans; Ciprofloxacin; Drug Combinations; Enoxacin; Flucytosine; Mepartricin; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Saccharomyces cerevisiae | 1988 |
Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes.
Topics: Administration, Topical; Amphotericin B; Burns; Candida; Cells, Cultured; Ciprofloxacin; Culture Techniques; Drug Therapy, Combination; Enterobacteriaceae; Fibroblasts; Humans; Keratinocytes; Microbial Sensitivity Tests; Norfloxacin; Nystatin; Skin; Skin, Artificial; Staphylococcus aureus | 1995 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candida albicans; Cefazolin; Ciprofloxacin; Corneal Ulcer; Female; Gentamicins; HIV Seropositivity; Humans; Miconazole; Pseudomonas aeruginosa; Staphylococcus aureus; Substance Abuse, Intravenous; Vancomycin; Visual Acuity | 1993 |
Fungal pneumonia: the predominant lung infection causing death in children undergoing bone marrow transplantation.
Topics: Adolescent; Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Bone Marrow Transplantation; Bronchoalveolar Lavage; Bronchoscopy; Candida albicans; Child; Child, Preschool; Ciprofloxacin; Cytomegalovirus; Female; Humans; Lung; Male; Pneumonia, Bacterial | 1996 |
Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Candidiasis; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Fluconazole; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Naphthyridines; Topoisomerase II Inhibitors | 1997 |
Fungal purulent constrictive pericarditis in a heart transplant patient.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candidiasis; Ciprofloxacin; Disease Susceptibility; Drainage; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Male; Middle Aged; Opportunistic Infections; Pericardiectomy; Pericarditis, Constrictive; Pleural Effusion; Pseudomonas aeruginosa; Pseudomonas Infections; Suppuration | 1998 |
Paranasal sinus mucormycosis: a report of two cases.
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; C-Reactive Protein; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Orbit; Otorhinolaryngologic Surgical Procedures; Plastic Surgery Procedures; Titanium; Tomography, X-Ray Computed | 2001 |
Multidrug-resistant Corynebacterium striatum pneumonia in a heart transplant recipient.
Topics: Amphotericin B; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Heart; Heart Transplantation; Humans; Male; Pneumonia, Bacterial; Radiography | 2003 |
[Recurrence of bacterial endophthalmitis after penetrating keratoplasty].
Topics: Abscess; Adult; Amphotericin B; Aqueous Humor; Candida albicans; Candidiasis; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Keratoplasty, Penetrating; Male; Postoperative Complications; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body | 2004 |
Pulmonary Pseudallescheria boydii infection with cutaneous zygomycosis after near drowning.
Topics: Accidents, Traffic; Adult; Amphotericin B; Anti-Infective Agents; Ciprofloxacin; Dermatomycoses; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Near Drowning; Pseudallescheria; Tomography, X-Ray Computed; Zygomycosis | 2004 |
Long-circulating sterically stabilized liposomes in the treatment of infections.
Topics: Ammonium Sulfate; Amphotericin B; Animals; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Carriers; Gentamicins; Humans; Infections; Liposomes; Molecular Structure; Pneumonia; Rats; Solubility | 2005 |
A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis.
Topics: Amphotericin B; Anti-Infective Agents; Antiprotozoal Agents; Child, Preschool; Ciprofloxacin; Genetic Predisposition to Disease; Humans; Leishmaniasis, Visceral; Male; Receptors, Interleukin-12; Recurrence; Salmonella Infections | 2007 |
Alterations in rat gut bacteria and intestinal epithelial cells following experimental exposure of antimicrobials.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cells, Cultured; Ciprofloxacin; Colony Count, Microbial; Digestive System; Epithelial Cells; Gram-Negative Bacteria; Gram-Positive Bacteria; Intestines; Male; Microbial Sensitivity Tests; Rats; Rats, Wistar | 2008 |
The antimicrobial activity of four commercial essential oils in combination with conventional antimicrobials.
Topics: Amphotericin B; Anti-Bacterial Agents; Candida albicans; Ciprofloxacin; Drug Antagonism; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Industrial Oils; Klebsiella pneumoniae; Melaleuca; Mentha piperita; Microbial Sensitivity Tests; Oils, Volatile; Rosmarinus; Staphylococcus aureus; Thymus Plant | 2009 |
Cryptococcal meningoradiculitis: an atypical presentation after initiation of antiretroviral therapy.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Retroviral Agents; Ceftriaxone; Ciprofloxacin; Female; HIV Infections; Humans; Lamivudine; Meningitis, Cryptococcal; Nevirapine; Radiculopathy; Stavudine | 2007 |
New 14-membered octaazamacrocyclic complexes of divalent transition metal ions with their antimicrobial and spectral studies.
Topics: Amphotericin B; Anti-Infective Agents; Bacteria; Ciprofloxacin; Electron Spin Resonance Spectroscopy; Fungi; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Metals; Microbial Sensitivity Tests; Transition Elements | 2010 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutrophils | 2011 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Enterococcus; Female; Fluconazole; Fungemia; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Multivariate Analysis; Neutropenia; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Time Factors; Transplantation, Homologous; Viridans Streptococci; Young Adult | 2014 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillus; Child; Ciprofloxacin; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Voriconazole | 2016 |
Synergistic activity of doped zinc oxide nanoparticles with antibiotics: ciprofloxacin, ampicillin, fluconazole and amphotericin B against pathogenic microorganisms.
Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nanoparticles; Zinc Oxide | 2016 |
Disseminated
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Cryptococcosis; Cryptococcus neoformans; Extracorporeal Membrane Oxygenation; Fluconazole; Flucytosine; Heart-Assist Devices; Humans; Immunocompetence; Intra-Aortic Balloon Pumping; Male; Middle Aged; Shock, Septic; ST Elevation Myocardial Infarction | 2019 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |